home / stock / immp / immp short
Short Information | Immutep Limited (NASDAQ:IMMP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,734,712 |
Total Actual Volume | 6,113,195 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 2 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 86,736 |
Average Short Percentage | 33.00% |
Is there a IMMP Short Squeeze or Breakout about to happen?
See the IMMP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-01-2024 | $2.66 | $2.6 | $2.66 | $2.57 | 204,919 | 64,946 | 31.69% |
04-30-2024 | $2.69 | $2.69 | $2.76 | $2.62 | 254,566 | 82,174 | 32.28% |
04-29-2024 | $2.78 | $2.67 | $2.8 | $2.56 | 612,450 | 166,890 | 27.25% |
04-26-2024 | $2.61 | $2.65 | $2.7 | $2.61 | 886,017 | 113,505 | 12.81% |
04-25-2024 | $2.66 | $2.6 | $2.66 | $2.55 | 246,865 | 73,682 | 29.85% |
04-24-2024 | $2.78 | $2.59 | $3.03 | $2.4 | 1,402,552 | 353,025 | 25.17% |
04-23-2024 | $2.35 | $2.51 | $2.58 | $2.3327 | 72,385 | 17,225 | 23.8% |
04-22-2024 | $2.2 | $2.32 | $2.46 | $2.2 | 170,669 | 55,449 | 32.49% |
04-19-2024 | $2.2 | $2.25 | $2.32 | $2.2 | 90,025 | 55,843 | 62.03% |
04-18-2024 | $2.25 | $2.2 | $2.33 | $2.15 | 270,168 | 107,539 | 39.8% |
04-17-2024 | $2.26 | $2.26 | $2.4 | $2.11 | 197,424 | 59,283 | 30.03% |
04-16-2024 | $2.31 | $2.26 | $2.38 | $2.26 | 84,528 | 19,733 | 23.34% |
04-15-2024 | $2.47 | $2.31 | $2.47 | $2.23 | 219,587 | 65,992 | 30.05% |
04-12-2024 | $2.52 | $2.49 | $2.6 | $2.43 | 112,793 | 55,887 | 49.55% |
04-11-2024 | $2.57 | $2.53 | $2.69 | $2.47 | 175,555 | 94,362 | 53.75% |
04-10-2024 | $2.71 | $2.53 | $2.72 | $2.51 | 98,592 | 30,200 | 30.63% |
04-09-2024 | $2.81 | $2.67 | $2.9 | $2.67 | 164,740 | 33,195 | 20.15% |
04-08-2024 | $2.85 | $2.78 | $3.05 | $2.72 | 400,244 | 125,869 | 31.45% |
04-05-2024 | $2.78 | $2.8 | $2.85 | $2.7 | 169,978 | 72,454 | 42.63% |
04-04-2024 | $2.55 | $2.76 | $2.776 | $2.51 | 279,138 | 87,459 | 31.33% |
News, Short Squeeze, Breakout and More Instantly...
Immutep Limited Company Name:
IMMP Stock Symbol:
NASDAQ Market:
Media Release Novel triple combination of efti with radiotherapy and anti-PD-1 therapy is well tolerated and has led to encouraging initial efficacy data in EFTISARC-NEO Phase II trial Four of six patients treated have very good, near-complete pathologic responses (primary endpoint of...
Media Release First clinical data from the safety lead-in of AIPAC-003 in metastatic breast cancer shows 90mg dosing of efti safe and well tolerated: 50% overall response rate, including one patient reporting a complete response (complete disappearance of all lesions), and a 100% disease ...
Wednesday, Immutep Limited (NASDAQ:IMMP) released preliminary topline results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) P...